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Major Histocompatibility Complex Class I
Chain-Related Gene A Polymorphisms and Extended
Haplotypes Are Associated with Familial
Alopecia Areata
Nazila Barahmani1, Mariza de Andrade2, Joshua P. Slusser2, Qing Zhang3 and Madeleine Duvic1
Alopecia areata (AA) is characterized by hair loss in patches and may progress to total loss of scalp hair, or total
loss of scalp and body hair. The major histocompatibility complex (HLA) is associated with susceptibility to AA,
as well as other autoimmune diseases. In addition to HLA molecules, non-HLA molecules including the major
histocompatibility complex class I chain-related gene A (MICA), a stress-inducible antigen, are also associated
with several autoimmune diseases. To investigate associations between AA and the HLA loci, two genes and
eight microsatellite markers spanning the HLA region were genotyped. MICA*6 was significantly associated
with all phenotypes of AA (P¼ 0.0083), whereas MICA*5.1 was significantly associated with patchy AA (P¼ 0.029).
Extended haplotype analysis shows the significant associations of haplotypes HLA-DQ1-DR6-MICA*5.1
(P¼ 0.004) and HLA-DQB1*0201-DR3-MICA*5.1 (P¼ 0.009) with AA. These results suggest that MICA is both a
potential candidate gene and part of an extended HLA haplotype that may contribute to susceptibility to and
severity of AA.
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INTRODUCTION
Alopecia areata (AA) is an organ-specific autoimmune
disease caused by T-cell infiltrates surrounding hair follicles.
The AA phenotype can vary from mild, patchy hair loss (AA)
to the total loss of scalp hair (alopecia totalis (AT)) or scalp
and body hair (alopecia universalis (AU)). This suggests that
AA is a multigenic, complex trait, and its discordance in twins
suggests that it is triggered by environmental factors such as
stress or viral infections in susceptible hosts (Cole and
Herzlinger, 1984; Jackow et al., 1998). The prevalence of
AA is approximately 0.1– 0.2% in the US population,
determined by a National Health and Nutrition Examination
Survey, 1971–1974 (Safavi, 1992).
HLA, encoded by the major histocompatibility complex
on chromosome 6, are probable major susceptibility loci in
AA and other autoimmune diseases. In previous studies, HLA-
DQB1*03 (*0301–*0303) alleles were present in 80% of all
patients with AA, regardless of phenotype, and in 92% of
patients with AT or AU (odds ratio¼12.14, P¼0.00003,
corrected). HLA-DRB1*1104 was associated with patchy AA
(odds ratio¼16) (Welsh et al., 1994; Duvic et al., 1995;
Colombe et al., 1999; de Andrade et al., 1999). Whether
specific HLA alleles or other HLA region genes, such as tumor
necrosis factor (TNF)-a, TNF-b, Notch, or major histocompat-
ibility complex class I chain-related gene A (MICA),
determine susceptibility to AA is not known.
The MICA molecule (previously PERB 11.1 molecule) is a
heat-shock- or oxidative-stress-induced antigen (Groh et al.,
1996; Yamamoto et al., 2001) belonging to the MIC gene
family, and is located about 46.5 kb centromeric to the HLA-B
gene. Five MICA polymorphisms (A4, A5, A5.1, A6, and A9),
determined by the number of alanine (GCT) repeats, are
located in the region encoding the transmembrane domain.
The A5.1 allele contains five GCT repeats, plus one extra
guanine nucleotide (GCT)2G(GCT)2 which causes a frame-
shift mutation with a premature termination codon, TAA. The
truncated protein, unlike the other MICA alleles, is poor in
hydrophobic amino acids, and may encode a soluble,
secreted form of MICA (Bahram et al., 1996). In order to
further study HLA gene associations in families, we used
polymorphic markers overlapping the entire HLA region.
RESULTS
To study the association of AA with the entire HLA locus, 81
individuals from 10 multiplex families, including 38 affected
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with AA, were genotyped in stage 1 using 10 selected
polymorphic markers (described in Materials and methods).
Preliminary evidence of association was found only between
MICA and AA. However, markers M6S151 and D6S2447
were not informative for this study because the allelic
distributions in the family members were not polymorphic
(data not shown). In stage 2, we expanded the study by
genotyping 176 affected and 231 unaffected members of an
additional 84 families for MICA alleles (Table 1). The MICA
allele 5.1 (MICA*5.1) was the most commonly encountered
in both affected individuals (40.1%) and unaffected relatives
(41.3%) (Table 1). No difference in the frequencies of
MICA*5.1 was found between 94 individuals with patchy
AA (38.8%) and 82 individuals with AT/AU (41.5%)
(P¼0.80).
As shown in Table 2, FBAT analysis was performed on
members of 94 families, using the unaffected parents and
siblings as controls. No significant association for any AA
severity phenotype was found between the MICA locus and
AA (P¼ 0.099). However, the MICA allele 6 (MICA*6) was
significantly associated with all collective AA phenotypes
(P¼0.0083). FBAT analyses were also performed for
individual AA phenotypes (patchy vs AT/AU) for each allele,
as well as all alleles combined. For the entire MICA locus,
there were no statistically significant associations between
MICA locus and patchy AA (P¼ 0.155) or the severe AT/AU
phenotype (P¼ 0.335). When the individual MICA alleles
were examined, the MICA*5.1 allele showed suggestive
evidence of association with patchy AA (P¼0.029) (Table 2).
Haplotype analysis results are shown in Tables 3–5. To
simplify the results of highly polymorphic HLA-DQ alleles,
we categorized them as DQ2 (DQB1*0201), DQ7
(DQB1*0301), DQ8 (DQB1*0302), DQ9 (DQB1*0303),
DQ4 (all DQB1*0400’s alleles), and DQ1 (all DQB1*
0500–*0600’s alleles) (Marsh et al., 2005). Recent HLA
nomenclature published by Marsh et al. (2005) divides
previous DQ1 alleles into DQ5 (all DQB1*0500’s alleles),
DQ6 (most DQB1*0600’s alleles), and DQ1 (DQB1*061101,
*061102, and *0612’s alleles). As we did not separate the
DQB1*0500’s and DQB1*0600’s alleles, we kept the
previous nomenclature for those particular alleles. The results
show that extended haplotypes DQ1-DR6-MICA*5.1
(P¼0.004) and DQB1*0201-DR3-MICA*5.1 (P¼0.009)
are significantly associated with AA. The extended haplo-
types DQB1*0201-DR3-MICA*5.1 (P¼ 0.008) and DQB1*
Table 1. Distribution of the MICA allele frequencies
(%) in 94 multiplex alopecia areata families
Affected probands and relatives
Alleles
Unaffected
(n1=231)
Total
(n=176)
Patchy AA
(n=94)
AT/AU
(n=82)
A4 12.1 13.6 15.4 11.6
A5 8.9 9.4 10.1 8.5
A5.1 41.3 40.1 38.8 41.5
A6 23.4 22.7 22.9 22.6
A9 14.3 14.2 12.8 15.8
AA=alopecia areata; AT/AU=alopecia totalis/alopecia universalis.
1Number of individuals.
Table 2. MICA locus and MICA allelic association
with AA using FBAT in 94 multiplex families1
AA2 (n=176)
Patchy AA
(n=94)
AT/AU
(n=82)
MICA locus 0.0997 0.1559 0.3357
MICA alleles
A4 0.3560 0.5374 0.5010
A5 0.7977 0.5816 0.7963
A5.1 0.0898 0.02943 0.8143
A6 0.00834 0.0761 0.0618
A9 0.8923 0.3006 0.1856
1Results are reported as P-values.
2AA includes all individuals with patchy AA and AT/AU.
3Suggestive evidence.
4Statistically significant.
Table 3. Haplotype analysis of HLA-DR, -DQ, and
-MICA in affected AA individuals compared to
unaffected related individuals
HLA-DQ
alleles
HLA-DR
alleles
MICA exon 5
alleles
Simulated P-
value
11 6 5.1 0.004
— 6 5.1 0.006
1 6 — 0.007
22 3 5.1 0.009
— 3 5.1 0.003
2 3 — 0.002
83 4 — 0.025
1DQ1=all DQB1*0500’s and *0600’s alleles.
2DQ2=DQB1*0201 allele.
3DQ8=DQB1*0302 allele.
Table 4. Haplotype analysis of HLA-DR, -DQ, and
MICA in patchy AA-affected individuals compared
to unaffected related individuals
HLA-DQ
alleles
HLA-DR
alleles
MICA exon 5
alleles
Simulated
P-value
2 3 5.1 0.008
— 3 5.1 0.013
2 3 — 0.0001
2 — 5.1 0.013
8 4 4 0.001
— 4 4 0.006
8 4 — 0.033
8 — 5.1 0.090
8 — 4 0.080
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0302-DR4-MICA*4 (P¼0.001) are associated with patchy
AA. Furthermore, the extended haplotypes DQ1-DR6-
MICA*5.1 (P¼0.037) and DQB1*0301-DR4-MICA*9
(P¼0.007) are associated with the most severe phenotype,
AT/AU (Tables 3–5).
DISCUSSION
Previous studies showed significant associations between AA
and class II HLA-DR and –DQ, but whether those alleles or
nearby genes confer disease susceptibility is uncertain (Welsh
et al., 1994; Colombe et al., 1999). We previously reported a
significant association between three alleles of HLA-DQB1
(*0302, *0601, and *0603) and two alleles of HLA-DR (DR4
and DR6) and AA multiplex families (de Andrade et al.,
1999). In this study, in addition to HLA-DR and -DQ, we
genotyped same families for MICA.
We show, for the first time, a significant association
between the MICA locus and AA, suggested in 10 multiplex
families and confirmed in 84 families. Although MICA*5.1
allele, reported at a frequency of 53% in American
Caucasians (Petersdorf et al., 1999), was also the most
common allele in our American Caucasians population
(40%), MICA*6 was found to be associated with AA of all
severity phenotypes considered together, whereas MICA*5.1
was associated with patchy persistent AA.
Like HLA alleles, MICA allelic polymorphisms are
associated with several autoimmune diseases and vary
among different population groups (Ota et al., 1997; Bahram,
2000). In Korean and Japanese populations, MICA*4 is
associated with type 1 diabetes and MICA*6 is a protective
allele (Kawabata et al., 2000; Park et al., 2001). In American
Caucasians, diabetes mellitus has been suggested to protect
against AA (Wang et al., 1994), and we found that AA is
associated with MICA*6. MICA*5.1 was associated with
mild, patchy AA in this study, and was associated with
psoriasis vulgaris in Korean and Chinese populations (Cheng
et al., 2000; Choi et al., 2000), and with adult onset of type I
diabetes mellitus in Italians (Gambelunghe et al., 2001).
Ethnicity may determine specific MICA allelic associations
with autoimmune diseases.
MICA is a candidate gene for susceptibility to autoimmune
diseases, including AA. MICA is a ligand for a heterodimer
receptor NKG2D-DAP10 found on natural killer cells, gd T
cells, and ab CD8þ T cells (Bauer et al., 1999), and is
expressed on the surface of epithelial cells, endothelial cells,
fibroblasts, keratinocytes, and monocytes (Zwirner et al.,
1999). MICA is also present in the epidermis of normal and
psoriasis lesions and hair follicles, where its presence could
attract cytotoxic or natural killer cells bearing its receptor
(Tay et al., 2000). The MICA*5.1 found in association with
patchy AA encodes a truncated protein transported in the
apical, rather than basolateral, membrane of the epithelial
cells (Bahram, 2000; Suemizu et al., 2002).
To determine whether a region, rather than genes, is
associated with AA, we performed extended haplotype
analysis for the susceptibility genes HLA-DQ, -DR, and
MICA. Extended haplotypes DQB1*0201-DR3-MICA*5.1
(P¼0.008) and DQB1*0302-DR4-MICA*4 (P¼0.001) were
significantly associated with patchy AA, while extended
haplotypes DQ1-DR6-MICA*5.1 (P¼0.037) and DQB1*
0301-DR4-MICA*9 (P¼0.007) were significantly associated
with severe AA. Considering all phenotypic severity together,
extended haplotypes DQ1-DR6-MICA*5.1 (P¼0.004) and
DQB1*0201-DR3-MICA*5.1 (P¼0.009) were significantly
associated with AA. This further supports our previous finding
of a highly significant association between -DQB1*03 alleles
(*0301–0303) and AT/AU in unrelated individuals and
in identical twins (Welsh et al., 1994; Jackow et al., 1998).
The extended haplotype association may confer increased
susceptibility of the locus to AA, and may distinguish the
mild from the severe phenotype. Although MICA is in
linkage disequilibrium with HLA-DQ and -DR (Kawabata
et al., 2000; Bilbao et al., 2002), MICA*6 could also
confer susceptibility to AA. To understand the role of
MICA in AA, further association studies with unrelated
controls and functional studies of the MICA*5.1 and *6
alleles are needed.
MATERIALS AND METHODS
Data collection
Study participants were identified in University of Texas dermatol-
ogy clinics and through a website: http://www.mdanderson.org/
departments/alopecia. Eligibility criteria for probands as well as
involved family members included a diagnosis and phenotype
determination of AA by the proband and the relative’s local
dermatologists. The criteria used were patchy AA (if there was any
patchy hair loss on the scalp or body), AT (complete scalp hair loss),
or AU (complete scalp and body hair loss). The study was conducted
according to the Declaration of Helsinki principles. Participants gave
written informed consent approved by the institution review board to
have blood samples drawn for genotyping. DNA was extracted from
fresh peripheral whole blood using standard methods (Stratagene, La
Jolla, CA).
Polymerase chain reaction and sequencing analysis
Genomic DNA (20–100 ng) was used to genotype by polymerase
chain reaction. MICA and TNF-b genes plus eight microsatellite
markers (M6S232, M6S233, D6S2447, M6S115, M6S234, M6S166,
Table 5. Haplotype analysis of HLA-DR, -DQ, and
-MICA in AT/AU-affected individuals compared
to unaffected related individuals
HLA-DQ
alleles
HLA-DR
alleles
MICA exon 5
alleles
Simulated
P-value
1 6 5.1 0.037
— 6 5.1 0.033
1 6 — 0.019
1 — 5.1 0.201
71 4 9 0.007
— 4 9 0.164
7 4 — 0.676
7 — 9 0.102
1DQ7=DQB1*0301 allele.
76 Journal of Investigative Dermatology (2006), Volume 126
N Barahmani et al.
MICA and Alopecia Areata
M6S101, and M6S151) previously described by Nair et al. (2000) at
website http://www.psoriasis.umcih.edu/hla2000/index.html were
used to genotype the HLA region in 10 multiplex families initially.
Polymerase chain reaction conditions for all polymorphic markers
were the same as those recommended by Nair et al., with the
exception of the M6S232, M6S233, and M6S234 markers, which
were cooled at 651C for 1 minute. Polymerase chain reaction
products were sized on a 2.5% ethidium bromide agarose gel with
‘‘BioMarkert Low’’ DNA ladder (BioVentures Inc., Murfreesboro,
TN), followed by DNA sequencing gels run on ABI 3100 and AB
3730XL Genetic Analyzers (Applied Biosystems, Foster City, CA).
Statistical analysis
To investigate the genetic composition of the major histocompatibility
complex region, we used a two-stage approach to select the genetic
markers. Under this approach, all the markers are genotyped and
tested at stage 1 using a subset of affected cases and unaffected
relatives, and the most promising markers are genotyped on the
remaining individuals and tested using all the individuals at stage 2.
This two-stage approach was shown to reduce the cost of the study
by half, with enough power to detect promising genetic markers
(Satagopan and Elston, 2003; Satagopan et al., 2004). In stage 1,
eight markers (M6S232, M6S233, D6S2447, M6S115, M6S234,
M6S166, M6S101, and M6S151) and two genes (TNF-b and
MICA) were genotyped in 10 of the largest multiplex American
Caucasian families (81 total individuals, of whom 38 had AA).
In stage 2, only the significant genetic markers were genotyped in the
other 84 families.
The family-based association tests (FBAT) (Laird et al., 2000;
Rabinowitz and Laird, 2000) were applied to identify the significant
genetic markers using the program FBAT (http://www.biostat.har
vard.edu/~fbat/fbat.htm). FBAT belongs to a class of tests that utilize
within- and between-family marker-inheritance patterns to test for
association and therefore are protected, by design, from the
confounding effect caused by an admixture. Different types of
designs, from sibships to extended families, can be used in the FBAT
program. FBAT evaluates the association between the specific
genetic marker and AA, and also the allelic association in a specific
marker and AA.
A genetic marker was considered to be genotyped in stage 2 if it
showed suggestive association (P-value between 0.05 and 0.01). In
stage 2, we reported only results that were statistically significant
(P-value between 0.01 and 0.001) and highly significant (P-value
o0.001). The multiple comparisons take into consideration these
lower P-values. The frequency of each allele was expressed as a
percentage of the total number of alleles. The frequencies were
estimated from the pedigree data using the method proposed by
Boehnke (1991) and the ILINK program of the LINKAGE package
(Lathrop et al., 1984).
In order to conduct a genetic dissection of the HLA region that
will help to identify the causative variants, we performed a
haplotype analysis including MICA, HLA-DR, and HLA-DQ alleles
using 176 affected and 231 unaffected related individuals (Lange
et al., 2003). We used the method developed by Horvath et al.
(2004), which is implemented in the software FBAT.
CONFLICT OF INTEREST
The author states no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by the National Institute of Arthritis and
Musculoskeletal and Skin (NIAMS) Grant AR45789, K24-CA86815, the
National Alopecia Areata Foundation (NAAF) research grant, and the grant
from Zarrow Family Foundation. This work was presented at the May 2004
meeting of the Society of Investigative Dermatology, in Providence, RI. We
thank The University of Texas MD Anderson Cancer Center’s core-laboratory
facility, funded by NCI Grant CA-16672 (DNA Analysis Core Facility), for
performing tests with the ABI 3100 and AB 3730XL Genetic Analyzer.
REFERENCES
Bahram S (2000) MIC genes: from genetics to biology. Adv Immunol 76:1–60
Bahram S, Mizuki N, Inoko H, Spies T (1996) Nucleotide sequence of the
human MHC class I MICA gene. Immunogenetics 44:80–1
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. (1999) Activation
of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Science 285:727–9
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L (2002)
HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque
families with celiac disease. Tissue Antigens 60:71–6
Boehnke M (1991) Allele frequency estimation from data on relatives. Am J
Hum Genet 48:22–5
Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC et al. (2000) The A5.1
allele of the major histocompatibility complex class I chain-related gene
A is associated with psoriasis vulgaris in Chinese. Br J Dermatol
143:324–9
Choi HB, Han H, Youn JI, Kim TY, Kim TG (2000) MICA 5.1 allele is a
susceptibility marker for psoriasis in the Korean population. Tissue
Antigens 56:548–50
Cole GW, Herzlinger D (1984) Alopecia universalis in identical twins. Int J
Dermatol 23:283
Colombe BW, Lou CD, Price VH (1999) The genetic basis of alopecia areata:
HLA association with patchy alopecia areata versus alopecia totalis and
alopecia universalis. J Invest Dermatol Symp Proc 4:216–9
de Andrade M, Jackow CW, Dahm N, Hordinsky M, Reveille JD, Duvic M
(1999) Alopecia areata in families: association with the HLA locus.
J Invest Dermatol Symp Proc 4:220–3
Duvic M, Welsh EA, Jackow C, Papadopoulos E, Reveille JD, Amos C (1995)
Analysis of HLA-D locus alleles in alopecia areata patients and families.
J Invest Dermatol 104(5 Suppl):5S–6S
Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F,
Brunetti P et al. (2001) Two distinct MICA gene markers discriminate
major autoimmune diabetes types. J Clin Endocrinol Metab 86:
3754–60
Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T (1996) Cell
stress-regulated human major histocompatibility complex class II gene
expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA
93:12445–50
Horvath S, Xu X, Lake S, Silverman E, Weiss S, Laird N (2004) Family-based
tests for associating haplotypes with general phenotype data: application
to asthma genetics. Gen Epidemiol 26:61–9
Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M (1998)
Alopecia areata and cytomegalovirus infection in twins: genes versus
environment. J Am Acad Dermatol 38:418–25
Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Hotta M, Ueda H et al.
(2000) Age-related association of MHC class I chain-related gene A
(MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum Immunol
61:624–9
Laird NM, Horvath S, Xu X (2000) Implementing a unified approach to
family-based tests of association. Genet Epidemiol 19(Suppl 1):
S36–S42
Lange C, DeMeo D, Silverman E, Weiss S, Laird NM (2003) Using the
noninformative families in family-based association tests: a powerful
new testing strategy. Am J Hum Genet 73:801–11
Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for multilocus linkage
analysis in humans. Proc Natl Acad Sci USA 81:3443–6
www.jidonline.org 77
N Barahmani et al.
MICA and Alopecia Areata
Marsh SGE, Albert ED, Bodmer WF (2005) Nomenclature for factors of the
HLA system, 2004. Tissue Antigens 65:301–69
Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E et al. (2000)
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval
telomeric to HLA-C. Am J Hum Genet 66:1833–44
Ota M, Katsuyama Y, Mizuki N, Ando H, Furihata K, Ono S et al. (1997)
Trinucleotide repeat polymorphism within exon 5 of the MICA gene
(MHC class I chain-related gene A): allele frequency data in the nine
population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan,
Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49:448–54
Park Y, Lee H, Sanjeevi CB, Eisenbarth GS (2001) MICA polymorphism is asso-
ciated with type 1 diabetes in the Korean population. Diabetes Care 24:33–8
Petersdorf EW, Shuler KB, Longton GM, Spies T, Hanson JA (1999) Population
study of allelic diversity in the human MHC class I-related MIC-A gene.
Immunogenetics 49:605–12
Rabinowitz D, Laird NM (2000) A unified approach to adjusting association
tests for population admixture with arbitrary pedigree structure and
arbitrary missing marker information. Hum Hered 50:211–23
Safavi K (1992) Prevalence of alopecia areata in the First National Health and
Nutrition Examination Survey. Arch Dermatol 128:702
Satagopan JM, Elston RC (2003) Optimal two-stage genotyping in population-
based association studies. Genet Epidemiol 25:149–57
Satagopan JM, Venkatraman ES, Begg CB (2004) Two stage designs for
gene–disease association studies with sample size constraints. Biometrics
60:589–597
Suemizu H, Radosavljevic M, Kimura M, Sadahiro S, Yoshimura S, Bahram S
et al. (2002) A basolateral sorting motif in the MICA cytoplasmic tail.
Proc Natl Acad Sci USA 99:2971–6
Tay GK, Hui J, Gaudieri S, Schmitt-Egenolf M, Martinez OP, Leelayuwat C
et al. (2000) PERB11 (MIC): a polymorphic MHC gene is expressed in
skin and single nucleotide polymorphisms are associated with psoriasis.
Clin Exp Immunol 119:553–8
Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI (1994)
Increased risk for type I (insulin-dependent) diabetes in relatives of
patients with alopecia areata (AA). Am J Med Genet 51:234–9
Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M (1994) Human
leukocyte antigen-DQB1*03 alleles are associated with alopecia areata.
J Invest Dermatol 103:758–63
Yamamoto K, Fujiyama Y, Audoh A, Bamba T, Okabe H (2001) Oxidative
stress increases MICA and MICB gene expression in the human colon
carcinoma cell line (CaCo-2). Biochim Biophys Acta 1526:10–2
Zwirner NW, Dole K, Stastny P (1999) Differential surface expression of MICA
by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum
Immunol 60:323–30
78 Journal of Investigative Dermatology (2006), Volume 126
N Barahmani et al.
MICA and Alopecia Areata
